{"resourceType": "Group", "meta": {"versionId": "45", "lastUpdated": "2024-08-02T16:18:39.693Z", "profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-definition"]}, "extension": [{"url": "http://hl7.org/fhir/StructureDefinition/artifact-author", "valueContactDetail": {"name": "Computable Publishing\u00ae: MAGIC-to-FEvIR Converter"}}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact", "valueRelatedArtifact": {"type": "part-of", "label": "Part of", "display": "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes", "resource": "https://fevir.net/resources/Composition/236363"}}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact", "valueRelatedArtifact": {"type": "cite-as", "citation": "ComparatorDefinition: Glucagon-Like Peptide-1 (GLP-1) receptor agonists [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing\u00ae: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236776. Revised 2024-08-01. Available at: https://fevir.net/resources/Group/236776. Computable resource at: https://fevir.net/resources/Group/236776."}}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-title", "valueString": "ComparatorDefinition: Glucagon-Like Peptide-1 (GLP-1) receptor agonists"}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-url", "valueUri": "https://fevir.net/resources/Group/236776"}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-publisher", "valueString": "Computable Publishing LLC"}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-copyright", "valueMarkdown": "https://creativecommons.org/licenses/by-nc-sa/4.0/"}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-useContext", "valueUsageContext": {"code": {"system": "https://fevir.net/resources/CodeSystem/179423", "code": "evidence-communication", "display": "Evidence Communication"}, "valueCodeableConcept": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "ExposureDefinition", "display": "ExposureDefinition"}]}}}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-contact", "valueContactDetail": {"telecom": [{"system": "email", "value": "support@computablepublishing.com"}]}}], "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "system": "https://fevir.net", "value": "236776", "assigner": {"display": "Computable Publishing LLC"}}, {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-comparator-85394-C-85798", "assigner": {"display": "Computable Publishing LLC"}}], "name": "Glucagon_Like_Peptide_1_GLP_1_receptor_agonists85394_C_85798", "membership": "definitional", "id": "236776", "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">[No data.]</div>"}, "description": "This Resource is referenced by another Resource used as an example in the EBMonFHIR Implementation Guide.", "modifierExtension": [{"url": "http://hl7.org/fhir/StructureDefinition/artifact-status", "valueCode": "active"}], "type": "animal"}